Qing Yi

22PUBLICATIONS
101CO-AUTHORS
Haematological tumoursMedical mycologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 30, 2026
Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma.

|Jul 07, 2026
Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma.

|Feb 16, 2026
T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers.

Yufei Zhang, Wei Xiong, Jianfei Qian

|Apr 03, 2025
Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss.

Liuling Xiao, Rui Duan, Wendao Liu

|Feb 06, 2025
Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma.

Li Qin, Luz Yurany Moreno Rueda, Upasana Ray

|Jan 04, 2025
Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors.

Wei Xiong, Liuling Xiao, Rui Duan

Pageof 4

Frequent Collaborators

8 joint publications

Qiang Wang

6 joint publications

Fenghuang Zhan

5 joint publications

Wei Xiong

4 joint publications

Robert Z Orlowski